Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Myocarditis

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Myocarditis in 2 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura, H1
Kunitsugu, I1
Fukuda, K1
Matsuzaki, M1
Sano, M1
Takahashi, T1
Zhu, SJ1
Sumino, H1
Saegusa, S1
Nakahashi, T1
Iwai, K1
Morimoto, S1
Kanda, T1

Other Studies

2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Myocarditis

ArticleYear
Diverse stage-dependent effects of glucocorticoids in a murine model of viral myocarditis.
    Journal of cardiology, 2013, Volume: 61, Issue:3

    Topics: Acute Disease; Animals; Coxsackievirus Infections; Cyclooxygenase Inhibitors; Dexamethasone; Disease

2013
Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis.
    Life sciences, 2005, Nov-26, Volume: 78, Issue:2

    Topics: Adiponectin; Animals; Body Weight; Cardiovirus Infections; Cyclooxygenase 2; Cyclooxygenase 2 Inhibi

2005